| 22/06 | ADRs End Lower; ArcelorMittal, AstraZeneca Trade Actively |  |
| 22/06 | ASTRAZENECA : l'EMA accepte un dossier dans le cancer du sein |  |
| 22/06 | Biocartis, AstraZeneca To Jointly Develop Companion Lung Cancer Diagnostic Test For Tag.. | |
| 22/06 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces New Agreement with AstraZeneca for .. | |
| 22/06 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces New Agreement with AstraZeneca for .. | |
| 22/06 | Biocartis Group NV Announces New Agreement with Astrazeneca for the Development and Mar.. | |
| 20/06 | Molecular Diagnostics Group Biocartis Introduces Lung Cancer Testing Panel | |
| 20/06 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Launch of its Rapid CE-marked IVD I.. | |
| 20/06 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Launch of its Rapid CE-marked IVD I.. | |
| 20/06 | Biocartis Group NV Announces Launch of its Rapid CE-marked IVD Idylla GeneFusion Panel .. | |
| 15/06 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Reaches Key Commercial Milestones: One-Millio.. | |
| 15/06 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Reaches Key Commercial Milestones: One-Millio.. | |
| 13/05 | PRESS RELEASE BIOCARTIS GROUP NV : Results of the Annual Shareholders' Meeting held on 13 .. | |
| 04/05 | PRESS RELEASE BIOCARTIS GROUP NV : New Study Led by Memorial Sloan Kettering Cancer Center.. | |
| 04/05 | PRESS RELEASE BIOCARTIS GROUP NV : New Study Led by Memorial Sloan Kettering Cancer Center.. | |
| 04/05 | Biocartis Group NV announces New Study Led by Memorial Sloan Kettering Cancer Center (N.. | |
| 25/04 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Presentation of Three Idylla™.. | |
| 25/04 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Presentation of Three Idylla™.. | |
| 21/04 | PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Presentation of First Prospective Vali.. | |
| 21/04 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Reports Results of First Quarter of 2022: On .. | |
| 21/04 | Biocartis Group NV Reconfirms Earnings Guidance of 2022 | |
| 12/04 | PRESS RELEASE BIOCARTIS GROUP NV : Invitation to the Annual Shareholders' Meeting | |
| 31/03 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Publication of 2021 Annual Report | |
| 24/02 | BIOCARTIS : Webcast presentation full year 2021 results | |
| 24/02 | TRANSCRIPT : Biocartis Group NV, 2021 Earnings Call, Feb 24, 2022 | |
| 24/02 | BOLSA DE MADRID : La incursión de Putin en Ucrania hace caer los mercados |  |
| 24/02 | Le raid de Poutine sur l'Ukraine culbute les marchés | |
| 24/02 | AVIS D'ANALYSTES DU JOUR : Carrefour, Eurofins, Faurecia, VAT Group, Paradox, Campari, Ele.. | |
| 24/02 | BIOCARTIS : Announces 2021 results and 2022 outlook | |
| 24/02 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces 2021 results and 2022 outlook | |
| 24/02 | Biocartis Group NV Reports Earnings Results for the Full Year Ended December 31, 2021 | |
| 24/02 | Biocartis Group NV Provides Earnings Guidance for the Year 2022 | |
| 24/02 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces 2021 results and 2022 outlook | |
| 17/02 | BIOCARTIS : Announces 2021 full year results on 24 february 2022 | |
| 17/02 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces 2021 full year results on 24 febru.. | |
| 08/02 | Biocartis, Ophiomics to Jointly Commercialize Liver Cancer Test | |
| 08/02 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis and Ophiomics to Collaborate on Liver Cancer.. | |
| 08/02 | Biocartis and Ophiomics to Collaborate on Liver Cancer Test | |
| 04/02 | PRESS RELEASE BIOCARTIS GROUP NV : Disclosure of a transparency notification | |
| 25/01 | Biocartis' Lung Cancer Test Shown to Improve Patient Survival Rates in UK Study | |
| 25/01 | PRESS RELEASE BIOCARTIS GROUP NV : Large UK Study Shows Rapid EGFR Testing with Idylla&tra.. | |
| 25/01 | Biocartis Group NV Announces Publication of Large New Study Comparing the Difference in.. | |
| 13/01 | BOLSA DE MADRID : ¿Preparado para el nuevo mundo? | |
| 13/01 | Prêt pour le monde d'après ? | |
| 13/01 | AVIS D'ANALYSTES DU JOUR : Stellantis, Vinci, STMicroelectronics, Soitec, ABB, Asos, Nokia.. | |
| 10/01 | BIOCARTIS : Meets 2021 key objectives | |
| 10/01 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis meets 2021 key objectives | |
| 2021 | Biocartis' COVID-19 Tests Found to Detect Omicron Variant | |
| 2021 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis' Idylla™ SARS-CoV-2 testing Successfull.. | |
| 2021 | Biocartis’ Idylla™ SARS-CoV-2 Testing Successfully Detects Omicron Variant | |
| 2021 | PRESS RELEASE BIOCARTIS GROUP NV : SeptiCyte® RAPID Receives 510(k) clearance by US FDA | |
| 2021 | Biocartis Group NV Announces SeptiCyte? Rapid Receives 510(K) Clearance by US FDA | |
| 2021 | Biocartis' Epidermal Growth Factor Receptor Mutation Test Shows Reduced Patient Managem.. | |
| 2021 | PRESS RELEASE BIOCARTIS GROUP NV : New Study Demonstrates Idylla™ EGFR Mutation Test.. | |
| 2021 | Biocartis Group NV Announces the Publication of New Study that Demonstrates That the Id.. | |
| 2021 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Q3 2021 Business Update | |
| 2021 | BIOCARTIS : Disclosure of a transparency notification | |
| 2021 | PRESS NEWS BIOCARTIS GROUP NV : Disclosure of a transparency notification | |
| 2021 | BIOCARTIS : Restarts Production Of ML2 Manufacturing Line | |
| 2021 | BIOCARTIS : Announces Restart of its High-Throughput Cartridge Manufacturing Line | |
| 2021 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Restart of its High-Throughput Cart.. | |
| 2021 | Biocartis Group NV Announces Restart of Its High-Throughput Cartridge Manufacturing Lin.. | |
| 2021 | BIOCARTIS : Disclosure of a transparency notification | |
| 2021 | PRESS RELEASE BIOCARTIS GROUP NV : Disclosure of a transparency notification | |
| 2021 | BIOCARTIS : Webcast presentation H1 2021 results | |
| 2021 | TRANSCRIPT : Biocartis Group NV, H1 2021 Earnings Call, Sep 02, 2021 | |
| 2021 | BIOCARTIS : Launches Idylla™ SARS-CoV-2/Flu/RSV Panel | |
| 2021 | BIOCARTIS : announces H1 2021 results | |
| 2021 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces H1 2021 results | |
| 2021 | Biocartis Group Nv Reports Earnings Results for the Half Year Ended June 30, 2021 | |
| 2021 | PRESS NEWS BIOCARTIS GROUP NV : Biocartis Launches Idylla™ SARS-CoV-2/Flu/RSV Panel | |
| 2021 | Biocartis Group NV Launches Idylla™ SARS-CoV-2/Flu/RSV Panel | |
| 2021 | BIOCARTIS : Disclosure of a transparency notification | |
| 2021 | PRESS RELEASE BIOCARTIS GROUP NV : Disclosure of a transparency notification | |
| 2021 | BIOCARTIS : Announces 2021 half-year results on 2 september 2021 | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Rapport
